ID   ERN1_HUMAN              Reviewed;         977 AA.
AC   O75460; A1L457; A8K8N8; A8MXS7; Q59EE2;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-2008, sequence version 2.
DT   10-MAY-2017, entry version 169.
DE   RecName: Full=Serine/threonine-protein kinase/endoribonuclease IRE1;
DE   AltName: Full=Endoplasmic reticulum-to-nucleus signaling 1;
DE   AltName: Full=Inositol-requiring protein 1;
DE            Short=hIRE1p;
DE   AltName: Full=Ire1-alpha;
DE            Short=IRE1a;
DE   Includes:
DE     RecName: Full=Serine/threonine-protein kinase;
DE              EC=2.7.11.1;
DE   Includes:
DE     RecName: Full=Endoribonuclease;
DE              EC=3.1.26.-;
DE   Flags: Precursor;
GN   Name=ERN1 {ECO:0000312|HGNC:HGNC:3449};
GN   Synonyms=IRE1 {ECO:0000312|EMBL:AAC25991.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAC25991.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AUTOPHOSPHORYLATION,
RP   GLYCOSYLATION, AND MUTAGENESIS OF LYS-599.
RC   TISSUE=Liver {ECO:0000312|EMBL:AAC25991.1};
RX   PubMed=9637683; DOI=10.1101/gad.12.12.1812;
RA   Tirasophon W., Welihinda A.A., Kaufman R.J.;
RT   "A stress response pathway from the endoplasmic reticulum to the
RT   nucleus requires a novel bifunctional protein kinase/endoribonuclease
RT   (Ire1p) in mammalian cells.";
RL   Genes Dev. 12:1812-1824(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Endothelial cell;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 2-977 (ISOFORM 2).
RC   TISSUE=Brain, and Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH TAOK3 AND TRAF2.
RX   PubMed=11278723; DOI=10.1074/jbc.M010677200;
RA   Yoneda T., Imaizumi K., Oono K., Yui D., Gomi F., Katayama T.,
RA   Tohyama M.;
RT   "Activation of caspase-12, an endoplastic reticulum (ER) resident
RT   caspase, through tumor necrosis factor receptor-associated factor 2-
RT   dependent mechanism in response to the ER stress.";
RL   J. Biol. Chem. 276:13935-13940(2001).
RN   [8] {ECO:0000305}
RP   FUNCTION, AND MUTAGENESIS OF LYS-599.
RX   PubMed=11175748; DOI=10.1038/35055065;
RA   Iwawaki T., Hosoda A., Okuda T., Kamigori Y., Nomura-Furuwatari C.,
RA   Kimata Y., Tsuru A., Kohno K.;
RT   "Translational control by the ER transmembrane kinase/ribonuclease
RT   IRE1 under ER stress.";
RL   Nat. Cell Biol. 3:158-164(2001).
RN   [9] {ECO:0000305}
RP   FUNCTION, HOMODIMERIZATION, ENZYME REGULATION, INTERACTION WITH HSPA5,
RP   AND MUTAGENESIS OF CYS-109; CYS-148 AND CYS-332.
RX   PubMed=12637535; DOI=10.1074/jbc.M300418200;
RA   Liu C.Y., Xu Z., Kaufman R.J.;
RT   "Structure and intermolecular interactions of the luminal dimerization
RT   domain of human IRE1alpha.";
RL   J. Biol. Chem. 278:17680-17687(2003).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-973, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ADP-RIBOSYLATION BY PARP16.
RX   PubMed=23103912; DOI=10.1038/ncb2593;
RA   Jwa M., Chang P.;
RT   "PARP16 is a tail-anchored endoplasmic reticulum protein required for
RT   the PERK-and IRE1alpha-mediated unfolded protein response.";
RL   Nat. Cell Biol. 14:1223-1230(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 24-390.
RX   PubMed=16973740; DOI=10.1073/pnas.0606480103;
RA   Zhou J., Liu C.Y., Back S.H., Clark R.L., Peisach D., Xu Z.,
RA   Kaufman R.J.;
RT   "The crystal structure of human IRE1 luminal domain reveals a
RT   conserved dimerization interface required for activation of the
RT   unfolded protein response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14343-14348(2006).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-244; MET-418; ARG-474; TRP-635;
RP   SER-700; PHE-769 AND LEU-830.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Senses unfolded proteins in the lumen of the endoplasmic
CC       reticulum via its N-terminal domain which leads to enzyme auto-
CC       activation. The active endoribonuclease domain splices XBP1 mRNA
CC       to generate a new C-terminus, converting it into a potent
CC       unfolded-protein response transcriptional activator and triggering
CC       growth arrest and apoptosis. {ECO:0000250|UniProtKB:Q9EQY0,
CC       ECO:0000269|PubMed:11175748, ECO:0000269|PubMed:12637535,
CC       ECO:0000269|PubMed:9637683}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:9637683}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: The kinase domain is activated by trans-
CC       autophosphorylation. Kinase activity is required for activation of
CC       the endoribonuclease domain. {ECO:0000269|PubMed:12637535,
CC       ECO:0000269|PubMed:9637683}.
CC   -!- SUBUNIT: Interacts with DAB2IP (via PH domain); the interaction
CC       occurs in a ER stress-induced dependent manner and is required for
CC       subsequent recruitment of TRAF2 to ERN1 (By similarity).
CC       Homodimer; disulfide-linked. Dimer formation is driven by
CC       hydrophobic interactions within the N-terminal luminal domains and
CC       stabilized by disulfide bridges. Also binds HSPA5, a negative
CC       regulator of the unfolded protein response. This interaction may
CC       disrupt homodimerization and prevent activation of ERN1. Interacts
CC       with TAOK3 and TRAF2. {ECO:0000250, ECO:0000269|PubMed:11278723,
CC       ECO:0000269|PubMed:12637535}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-371750, EBI-371750;
CC       O08734:Bak1 (xeno); NbExp=2; IntAct=EBI-371750, EBI-822441;
CC       Q07812:BAX; NbExp=2; IntAct=EBI-371750, EBI-516580;
CC       Q07813:Bax (xeno); NbExp=2; IntAct=EBI-371750, EBI-700711;
CC       P11021:HSPA5; NbExp=3; IntAct=EBI-371750, EBI-354921;
CC       P20029:Hspa5 (xeno); NbExp=2; IntAct=EBI-371750, EBI-772325;
CC       Q86TM6:SYVN1; NbExp=2; IntAct=EBI-371750, EBI-947849;
CC       Q9H2K8:TAOK3; NbExp=3; IntAct=EBI-371750, EBI-1384100;
CC       Q12933:TRAF2; NbExp=3; IntAct=EBI-371750, EBI-355744;
CC       Q969M3:YIPF5; NbExp=3; IntAct=EBI-371750, EBI-2124787;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:9637683}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:9637683}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75460-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75460-2; Sequence=VSP_034582, VSP_034583;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. High levels observed
CC       in pancreatic tissue. {ECO:0000269|PubMed:9637683}.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:9637683}.
CC   -!- PTM: ADP-ribosylated by PARP16 upon ER stress, which increases
CC       both kinase and endonuclease activities.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF059198; AAC25991.1; -; mRNA.
DR   EMBL; AK292403; BAF85092.1; -; mRNA.
DR   EMBL; DA254477; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB209869; BAD93106.1; -; mRNA.
DR   EMBL; AC005803; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025362; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94214.1; -; Genomic_DNA.
DR   EMBL; BC130405; AAI30406.1; -; mRNA.
DR   EMBL; BC130407; AAI30408.1; -; mRNA.
DR   EMBL; BI912495; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS45762.1; -. [O75460-1]
DR   RefSeq; NP_001424.3; NM_001433.3. [O75460-1]
DR   UniGene; Hs.133982; -.
DR   UniGene; Hs.700027; -.
DR   UniGene; Hs.744953; -.
DR   PDB; 2HZ6; X-ray; 3.10 A; A=24-390.
DR   PDB; 3P23; X-ray; 2.70 A; A/B/C/D=547-977.
DR   PDB; 4U6R; X-ray; 2.50 A; A=547-977.
DR   PDB; 4YZ9; X-ray; 2.46 A; A/B/C=562-966.
DR   PDB; 4YZC; X-ray; 2.49 A; A/B=562-966.
DR   PDB; 4YZD; X-ray; 3.10 A; A/B/C=562-966.
DR   PDB; 4Z7G; X-ray; 2.60 A; A/B=562-977.
DR   PDB; 4Z7H; X-ray; 2.90 A; A/B=562-977.
DR   PDB; 5HGI; X-ray; 2.58 A; A=547-977.
DR   PDBsum; 2HZ6; -.
DR   PDBsum; 3P23; -.
DR   PDBsum; 4U6R; -.
DR   PDBsum; 4YZ9; -.
DR   PDBsum; 4YZC; -.
DR   PDBsum; 4YZD; -.
DR   PDBsum; 4Z7G; -.
DR   PDBsum; 4Z7H; -.
DR   PDBsum; 5HGI; -.
DR   ProteinModelPortal; O75460; -.
DR   SMR; O75460; -.
DR   BioGrid; 108391; 28.
DR   DIP; DIP-31711N; -.
DR   IntAct; O75460; 17.
DR   MINT; MINT-3001268; -.
DR   STRING; 9606.ENSP00000401445; -.
DR   BindingDB; O75460; -.
DR   ChEMBL; CHEMBL1163101; -.
DR   GuidetoPHARMACOLOGY; 2020; -.
DR   iPTMnet; O75460; -.
DR   PhosphoSitePlus; O75460; -.
DR   BioMuta; ERN1; -.
DR   EPD; O75460; -.
DR   MaxQB; O75460; -.
DR   PaxDb; O75460; -.
DR   PeptideAtlas; O75460; -.
DR   PRIDE; O75460; -.
DR   DNASU; 2081; -.
DR   Ensembl; ENST00000433197; ENSP00000401445; ENSG00000178607. [O75460-1]
DR   Ensembl; ENST00000606895; ENSP00000475519; ENSG00000178607. [O75460-2]
DR   GeneID; 2081; -.
DR   KEGG; hsa:2081; -.
DR   UCSC; uc002jdz.3; human. [O75460-1]
DR   CTD; 2081; -.
DR   DisGeNET; 2081; -.
DR   GeneCards; ERN1; -.
DR   H-InvDB; HIX0014084; -.
DR   HGNC; HGNC:3449; ERN1.
DR   HPA; CAB009495; -.
DR   HPA; HPA027730; -.
DR   MIM; 604033; gene.
DR   neXtProt; NX_O75460; -.
DR   OpenTargets; ENSG00000178607; -.
DR   PharmGKB; PA27861; -.
DR   eggNOG; KOG1027; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00390000015684; -.
DR   HOGENOM; HOG000012929; -.
DR   HOVERGEN; HBG051506; -.
DR   InParanoid; O75460; -.
DR   KO; K08852; -.
DR   OMA; SEDCKDN; -.
DR   OrthoDB; EOG091G049V; -.
DR   PhylomeDB; O75460; -.
DR   TreeFam; TF313986; -.
DR   Reactome; R-HSA-381070; IRE1alpha activates chaperones.
DR   SignaLink; O75460; -.
DR   ChiTaRS; ERN1; human.
DR   EvolutionaryTrace; O75460; -.
DR   GeneWiki; ERN1; -.
DR   GenomeRNAi; 2081; -.
DR   PRO; PR:O75460; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000178607; -.
DR   CleanEx; HS_ERN1; -.
DR   Genevisible; O75460; HS.
DR   GO; GO:1990597; C:AIP1-IRE1 complex; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:1990332; C:Ire1 complex; NAS:ParkinsonsUK-UCL.
DR   GO; GO:1990630; C:IRE1-RACK1-PP2A complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990604; C:IRE1-TRAF2-ASK1 complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005637; C:nuclear inner membrane; IEA:Ensembl.
DR   GO; GO:0043531; F:ADP binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004521; F:endoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030544; F:Hsp70 protein binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0051879; F:Hsp90 protein binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0005161; F:platelet-derived growth factor receptor binding; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007257; P:activation of JUN kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006987; P:activation of signaling protein activity involved in unfolded protein response; IDA:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0035924; P:cellular response to vascular endothelial growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0001935; P:endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:1901142; P:insulin metabolic process; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006402; P:mRNA catabolic process; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006379; P:mRNA cleavage; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0070055; P:mRNA endonucleolytic cleavage involved in unfolded protein response; IDA:WormBase.
DR   GO; GO:0070054; P:mRNA splicing, via endonucleolytic cleavage and ligation; IDA:UniProtKB.
DR   GO; GO:0036289; P:peptidyl-serine autophosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1990579; P:peptidyl-serine trans-autophosphorylation; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1900103; P:positive regulation of endoplasmic reticulum unfolded protein response; IMP:UniProtKB.
DR   GO; GO:0033120; P:positive regulation of RNA splicing; IDA:UniProtKB.
DR   GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0016241; P:regulation of macroautophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR010513; KEN_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR018391; PQQ_beta_propeller_repeat.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR018997; PUB_domain.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF06479; Ribonuc_2-5A; 1.
DR   SMART; SM00564; PQQ; 5.
DR   SMART; SM00580; PUG; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF50998; SSF50998; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51392; KEN; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ADP-ribosylation; Alternative splicing; Apoptosis;
KW   ATP-binding; Complete proteome; Disulfide bond; Endoplasmic reticulum;
KW   Glycoprotein; Hydrolase; Kinase; Magnesium; Membrane; Metal-binding;
KW   Multifunctional enzyme; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Signal; Transcription; Transcription regulation; Transferase;
KW   Transmembrane; Transmembrane helix; Unfolded protein response.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    977       Serine/threonine-protein
FT                                kinase/endoribonuclease IRE1.
FT                                /FTId=PRO_0000024327.
FT   TOPO_DOM     19    443       Lumenal. {ECO:0000255}.
FT   TRANSMEM    444    464       Helical. {ECO:0000255}.
FT   TOPO_DOM    465    977       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      571    832       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      835    963       KEN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00725}.
FT   NP_BIND     577    585       ATP. {ECO:0000250|UniProtKB:P32361,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   ACT_SITE    688    688       Proton acceptor.
FT                                {ECO:0000250|UniProtKB:P32361,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159,
FT                                ECO:0000255|PROSITE-ProRule:PRU10027}.
FT   BINDING     599    599       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159,
FT                                ECO:0000269|PubMed:9637683}.
FT   MOD_RES     973    973       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   CARBOHYD    176    176       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      19     70       IFGSTSTVTLPETLLFVSTLDGSLHAVSKRTGSIKWTLKED
FT                                PVLQVPTHVEE -> VSDRGAWGGGQLATAGSGPGQRRGAG
FT                                AGVRAGSATAAARCPVSPAVGGSGRA (in isoform
FT                                2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034582.
FT   VAR_SEQ      71    977       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_034583.
FT   VARIANT     244    244       N -> S (in a renal clear cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040488.
FT   VARIANT     418    418       V -> M (in dbSNP:rs55869215).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040489.
FT   VARIANT     474    474       L -> R (in a lung adenocarcinoma sample;
FT                                somatic mutation; dbSNP:rs186305118).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040490.
FT   VARIANT     635    635       R -> W (in a gastric adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs146710304).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040491.
FT   VARIANT     700    700       N -> S. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040492.
FT   VARIANT     769    769       S -> F (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040493.
FT   VARIANT     830    830       P -> L (in an ovarian serous carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040494.
FT   MUTAGEN     109    109       C->S: No effect on dimerization.
FT                                {ECO:0000269|PubMed:12637535}.
FT   MUTAGEN     148    148       C->S: No effect on dimerization. Weakens
FT                                dimer; when associated with S-148.
FT                                {ECO:0000269|PubMed:12637535}.
FT   MUTAGEN     332    332       C->S: No effect on dimerization. Weakens
FT                                dimer; when associated with S-332.
FT                                {ECO:0000269|PubMed:12637535}.
FT   MUTAGEN     599    599       K->A: Loss of autophosphorylation and of
FT                                endoribonuclease activity. Inhibition of
FT                                growth arrest.
FT                                {ECO:0000269|PubMed:11175748,
FT                                ECO:0000269|PubMed:9637683}.
FT   CONFLICT    190    191       DV -> EG (in Ref. 1; AAC25991).
FT                                {ECO:0000305}.
FT   CONFLICT    768    768       I -> V (in Ref. 1; AAC25991).
FT                                {ECO:0000305}.
FT   CONFLICT    816    816       D -> G (in Ref. 2; BAF85092).
FT                                {ECO:0000305}.
FT   CONFLICT    824    825       KH -> ND (in Ref. 1; AAC25991).
FT                                {ECO:0000305}.
FT   CONFLICT    880    880       V -> D (in Ref. 1; AAC25991).
FT                                {ECO:0000305}.
FT   CONFLICT    904    904       M -> T (in Ref. 2; BAF85092).
FT                                {ECO:0000305}.
FT   CONFLICT    924    924       S -> T (in Ref. 1; AAC25991).
FT                                {ECO:0000305}.
FT   STRAND       32     37       {ECO:0000244|PDB:2HZ6}.
FT   STRAND       40     46       {ECO:0000244|PDB:2HZ6}.
FT   TURN         47     49       {ECO:0000244|PDB:2HZ6}.
FT   STRAND       52     57       {ECO:0000244|PDB:2HZ6}.
FT   STRAND       73     75       {ECO:0000244|PDB:2HZ6}.
FT   TURN         77     79       {ECO:0000244|PDB:2HZ6}.
FT   STRAND       82     84       {ECO:0000244|PDB:2HZ6}.
FT   STRAND       93     95       {ECO:0000244|PDB:2HZ6}.
FT   HELIX       100    104       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      120    128       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      154    164       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      168    172       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      176    182       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      197    201       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      205    209       {ECO:0000244|PDB:2HZ6}.
FT   TURN        211    213       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      216    221       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      226    231       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      238    240       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      243    246       {ECO:0000244|PDB:2HZ6}.
FT   HELIX       247    264       {ECO:0000244|PDB:2HZ6}.
FT   HELIX       273    279       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      280    284       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      286    288       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      297    300       {ECO:0000244|PDB:2HZ6}.
FT   TURN        359    361       {ECO:0000244|PDB:2HZ6}.
FT   STRAND      564    566       {ECO:0000244|PDB:4YZC}.
FT   STRAND      567    580       {ECO:0000244|PDB:4YZ9}.
FT   TURN        581    583       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      584    591       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      594    601       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       603    605       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       606    617       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      628    633       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      638    642       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      645    648       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       649    655       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       657    661       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       665    681       {ECO:0000244|PDB:4YZ9}.
FT   TURN        691    693       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      694    697       {ECO:0000244|PDB:4YZ9}.
FT   TURN        701    703       {ECO:0000244|PDB:4YZD}.
FT   STRAND      707    709       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       712    714       {ECO:0000244|PDB:4YZC}.
FT   HELIX       740    743       {ECO:0000244|PDB:4YZC}.
FT   HELIX       754    768       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       778    780       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       781    787       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      793    795       {ECO:0000244|PDB:4YZC}.
FT   HELIX       800    812       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       817    819       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       823    827       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       830    832       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       835    849       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      854    856       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       857    865       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       867    870       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      874    878       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       880    887       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      888    890       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       897    909       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       911    913       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       916    922       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       927    936       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       940    947       {ECO:0000244|PDB:4YZ9}.
FT   HELIX       948    951       {ECO:0000244|PDB:4YZ9}.
FT   STRAND      952    954       {ECO:0000244|PDB:3P23}.
FT   HELIX       955    957       {ECO:0000244|PDB:4YZ9}.
FT   TURN        958    960       {ECO:0000244|PDB:4YZ9}.
SQ   SEQUENCE   977 AA;  109735 MW;  A2DF808CCE015536 CRC64;
     MPARRLLLLL TLLLPGLGIF GSTSTVTLPE TLLFVSTLDG SLHAVSKRTG SIKWTLKEDP
     VLQVPTHVEE PAFLPDPNDG SLYTLGSKNN EGLTKLPFTI PELVQASPCR SSDGILYMGK
     KQDIWYVIDL LTGEKQQTLS SAFADSLCPS TSLLYLGRTE YTITMYDTKT RELRWNATYF
     DYAASLPEDD VDYKMSHFVS NGDGLVVTVD SESGDVLWIQ NYASPVVAFY VWQREGLRKV
     MHINVAVETL RYLTFMSGEV GRITKWKYPF PKETEAKSKL TPTLYVGKYS TSLYASPSMV
     HEGVAVVPRG STLPLLEGPQ TDGVTIGDKG ECVITPSTDV KFDPGLKSKN KLNYLRNYWL
     LIGHHETPLS ASTKMLERFP NNLPKHRENV IPADSEKKSF EEVINLVDQT SENAPTTVSR
     DVEEKPAHAP ARPEAPVDSM LKDMATIILS TFLLIGWVAF IITYPLSMHQ QQQLQHQQFQ
     KELEKIQLLQ QQQQQLPFHP PGDTAQDGEL LDTSGPYSES SGTSSPSTSP RASNHSLCSG
     SSASKAGSSP SLEQDDGDEE TSVVIVGKIS FCPKDVLGHG AEGTIVYRGM FDNRDVAVKR
     ILPECFSFAD REVQLLRESD EHPNVIRYFC TEKDRQFQYI AIELCAATLQ EYVEQKDFAH
     LGLEPITLLQ QTTSGLAHLH SLNIVHRDLK PHNILISMPN AHGKIKAMIS DFGLCKKLAV
     GRHSFSRRSG VPGTEGWIAP EMLSEDCKEN PTYTVDIFSA GCVFYYVISE GSHPFGKSLQ
     RQANILLGAC SLDCLHPEKH EDVIARELIE KMIAMDPQKR PSAKHVLKHP FFWSLEKQLQ
     FFQDVSDRIE KESLDGPIVK QLERGGRAVV KMDWRENITV PLQTDLRKFR TYKGGSVRDL
     LRAMRNKKHH YRELPAEVRE TLGSLPDDFV CYFTSRFPHL LAHTYRAMEL CSHERLFQPY
     YFHEPPEPQP PVTPDAL
//
